Skip to main content
logo
Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.79
-0.05 (-0.19%)
At close: Jul 2, 2026, 4:00 PM EDT
25.81
+0.02 (0.08%)
After-hours: Jul 2, 2026, 4:10 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
ZORYVE Cream 0.3% Revenue
130.28M121.00M85.08M
ZORYVE Cream 0.3% Revenue Growth
7.67%42.21%191.52%
ZORYVE Foam Revenue
201.28M181.89M71.54M
ZORYVE Foam Revenue Growth
10.66%154.26%-
ZORYVE Cream 0.15% Revenue
79.80M68.27M9.92M
ZORYVE Cream 0.15% Revenue Growth
16.88%588.18%-
ZORYVE Cream 0.05% Revenue
-911.00K-
Total Product Revenue
413.62M372.07M166.54M
Total Product Revenue Growth
11.17%123.41%470.62%
Other Segment Revenue
-4.00M30.00M
Other Segment Revenue Growth
--86.67%-1.38%
Revenue (Other)
2.00M-911.00K-
Revenue (Total)
415.62M376.07M196.54M
Revenue (Total) Growth
10.52%91.34%229.73%